Cold sore virus Re-Injected into brain tumors in search for new treatment
NCT ID NCT06193174
Summary
This early-stage trial tested the safety of giving a second dose of an experimental treatment called C134 to adults with recurrent malignant brain tumors. C134 is a genetically modified cold sore virus designed to infect and kill tumor cells when injected directly into the brain. The study was terminated after enrolling only one patient to assess safety and see if repeat treatment could help control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANAPLASTIC ASTROCYTOMA OF BRAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
Conditions
Explore the condition pages connected to this study.